Jacob J. Orme

机构：Mayo Clinic, Mayo Clinic in Arizona, Mayo Clinic in Florida · ORCID：0000-0002-0319-0239

发表论文 266 篇 · 总被引 1467 次 · h-index 20

代表论文

ERBB2 copy number alterations and protein expression in bladder cancer treated by cystectomy (2026 · Human Pathology)
Paclitaxel and carboplatin after disease progression on immune checkpoint inhibitor for patients with metastatic urothelial carcinoma (2026 · Exploration of Targeted Anti-tumor Therapy)
CAST-AI: Cystectomy After Systemic Therapy With Antibody-Drug Conjugate and Immunotherapy (2026 · JCO oncology advances.)
Supplementary Figure 3 from Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer (2026)
Supplementary Figure 1 from Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer (2026)
Supplementary Figure 2 from Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer (2026)